Hospital administrators expect the surging omicron wave to affect elective surgeries for up to four weeks, potentially resulting in a 7% revenue hit for exposed medtech companies.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,